Pioneers early cancer detection using AI and biology to develop affordable, multi-cancer blood tests for routine screening and prevention.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing low-cost, multi-cancer blood tests. Harbinger envisions a future where, instead of keeping cancer from spreading, it could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems and societies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Catalyst Group, The
Flagship Pioneering
M&G Investments
Partners Investment Co.
Pictet
Harbinger Health Valuations & Financials
View real-time NPM data on Harbinger Health stock including daily Harbinger Health stock price estimates, valuation history, and historical share price information. Access Harbinger Health financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Harbinger Health pricing across six independent market signals. Looking for private company due diligence data sources on Harbinger Health? Get in touch to learn more.
Similar Companies
like Harbinger Health
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Ensoma
Healthcare & Life Sciences
Develops in-body gene editing technology to modify blood stem cells, creating single-treatment solutions for diseases.
Orbital Sentry
Streams real-time satellite data to enable early wildfire detection and continuous climate risk monitoring.
Wheel Health
Healthcare & Life Sciences
Telehealth platform providing virtual care infrastructure and clinician network to help organizations deliver and scale digital health services.
Twenty
Industrializing offensive cyber capabilities for the U.S. military and Intelligence Community.
The Bounty App
Media & Entertainment
A creator monetization platform that connects influencers with brands, facilitating paid collaborations and product promotions on social media.
Neighbor
Connects people needing storage or parking with neighbors offering unused space for belongings or vehicles, all booked easily online.
Inflammatix
Healthcare & Life Sciences
Develops rapid tests that analyze the immune system to diagnose acute infections and sepsis.
Planted Solar
Delivers a platform combining software, adaptive solar arrays, and automation for faster, more efficient, and cost-effective solar power plants.
FAQ
We have answers
Harbinger Health stock does not trade on public stock exchanges. Harbinger Health stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Harbinger Health stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Harbinger Health Stock does not trade on public stock exchanges. In order to sell Harbinger Health shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Harbinger Health does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Harbinger Health share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Harbinger Health stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Harbinger Health stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Harbinger Health stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Harbinger Health is a private company and has not had an IPO. There is currently no Harbinger Health IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Harbinger Health IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
